Filing summary
Entity mismatch: The supplied filing is for ESGEN Acquisition Corporation, not Zeo Energy Corp. It is a SPAC 10-Q for the quarter ended September 30, 2022, filed November 10, 2022. Its results do not describe Zeo Energy’s operating business.
Business context and reporting period
ESGEN was formed to pursue a business combination and reported that it had not selected a target or begun operations. It raised capital in an October 2021 IPO and held most proceeds in a trust pending a transaction. The filing covers the three and nine months ended September 30, 2022.
Financial metrics
| Metric | Reported amount |
|---|---|
| Operating revenue | None; the company said it would not generate operating revenue before a business combination. |
| Net income, Q3 2022 | $4.26 million, versus a $1,690 loss in Q3 2021. |
| Net income, nine months 2022 | $11.64 million, versus a $15,393 loss from inception through September 30, 2021. |
| Key income sources, nine months 2022 | $11.61 million gain from changes in warrant fair value and $1.63 million trust interest, partly offset by $1.60 million operating costs. Income was therefore primarily non-operating and included a noncash fair-value gain. |
| Cash and trust assets, September 30, 2022 | $890,273 cash outside the trust; $283.15 million in trust investments. |
| Cash flow, nine months 2022 | $433,630 used in operating activities; ending cash was $890,273. |
| Liabilities and liquidity | $1.09 million accounts payable and accrued expenses; $171,346 related-party promissory note; $114,193 due to related parties; $9.66 million deferred underwriting discount payable upon a business combination. Warrant liabilities were $2.37 million. |
| Shareholders’ deficit | $12.34 million at September 30, 2022. |
Changes versus prior periods
- Trust assets rose from $281.52 million at December 31, 2021 to $283.15 million, reflecting interest and redemption-value accretion.
- Warrant liabilities fell from $13.98 million to $2.37 million; the resulting fair-value gain substantially drove reported 2022 income.
- Cash outside the trust fell from $1.32 million to $890,273, while accounts payable and accrued expenses increased from $411,416 to $1.09 million.
- Prior-year operating results reflect the company’s formation period and are not a like-for-like operating-company comparison.
Outlook, risks, and unusual items
- Management said cash outside the trust was insufficient to fund operations for the next 12 months absent a business combination and disclosed substantial doubt about the company’s ability to continue as a going concern.
- The stated business-combination deadline was January 22, 2023, unless extended; the filing also describes a possible extension to July 22, 2023. Failure to complete a transaction or obtain an extension could lead to liquidation and dissolution.
- No target had been selected, and any sponsor or affiliate working-capital loans were discretionary; none were outstanding at quarter-end.
- The $9.66 million deferred underwriting discount is contingent on completing a business combination. Public shares are redeemable, with $283.15 million recorded at redemption value outside permanent equity.
- Disclosure controls were deemed ineffective due to a previously identified material weakness involving insufficient qualified accounting resources and earnings-per-share calculations. Management described remediation plans but gave no assurance they would be effective.
- Management reported no appreciable company-specific COVID-19 impact at that time, while noting uncertainty. The filing reported no legal proceedings and no material changes to previously disclosed risk factors.
Investor verification priorities
- Confirm the intended company: this filing names ESGEN Acquisition Corporation, not Zeo Energy Corp.
- Verify the business-combination deadline, any extension, and transaction status after the filing date.
- Assess whether cash outside the trust and available financing could cover operating and transaction costs.
- Separate recurring operating performance from trust interest and noncash warrant fair-value gains.
- Review the accounting-control material weakness and progress on remediation.
- Confirm redemption terms, deferred underwriting fees, and potential dilution from founder shares and warrants.